{"id":100490,"date":"2013-10-21T11:12:39","date_gmt":"2013-10-21T11:12:39","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=100490"},"modified":"2013-10-21T11:12:39","modified_gmt":"2013-10-21T11:12:39","slug":"crestere-cu-6-a-vanzarilor-grupului-roche-in-primele-9-luni-ale-anului","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=100490","title":{"rendered":"Cre\u015ftere cu 6% a v\u00e2nz\u0103rilor Grupului Roche \u00een primele 9 luni ale anului"},"content":{"rendered":"<p>\nSeverin Schwan, CEO al Roche, a declarat cu privire la rezultatele companiei \u00een primele trei trimestre: \u201cCererea pentru produsele oferite de ambele noastre divizii r\u0103m\u00e2ne \u00een continuare ridicat\u0103. Ne vom \u00eendeplini obiectivele asumate pentru acest an. Sunt \u00eenc\u00e2ntat de rezultatele deosebite ale noilor noastre medicamente oncologice, care au \u00eembun\u0103t\u0103\u0163it semnificativ supravie\u0163uirea bolnavilor cu forme agresive de cancer.\u201d<\/p>\n<p>\nV\u00e2nzarile Diviziei de Farmaceutice a Roche au crescut cu 7% \u00een primele 9 luni ale anului 2013, ajung\u00e2nd&nbsp; la 27.2 miliarde de franci elve\u0163ieni. Aceast\u0103 cre\u015ftere s-a datorat \u00een special produselor din portofoliul de oncologie, dar \u015fi perfoman\u0163elor \u00eenregistrate de medicamentele destinate tratamentului poliartritei reumatoide.<\/p>\n<p>\nLinia de cercetare \u015fi dezvoltare a Roche include \u00een acest moment 65 de noi molecule, dou\u0103 treimi dintre acestea urm\u00e2nd a fi \u00eenso\u0163ite de teste companion de diagnostic, ceea ce \u00eent\u0103re\u015fte pozi\u0163ia companiei \u00een domeniul medicinei personalizate.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Grupul farmaceutic elve\u0163ian Roche anun\u0163\u0103 o cre\u015ftere a v\u00e2nz\u0103rilor globale \u00een primele nou\u0103 luni ale anului 2013, cu 6%, la o rat\u0103 de schimb constant\u0103, ajung\u00e2nd la 34.9 miliarde franci elve\u0163ieni, datorit\u0103 cererii crescute pentru medicamentele destinate tratamentului cancerului \u015fi testele de diagnostic destinate laboratoarelor clinice. V\u00e2nz\u0103rile \u00eenregistrate \u00een al treilea trimestru al anului au cresut cu 8% comparativ cu aceea\u015fi perioad\u0103 din 2012.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[8088,518,8623,7212],"class_list":["post-100490","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-farma","tag-rezultate","tag-roche","tag-vanzari"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/100490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=100490"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/100490\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=100490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=100490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=100490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}